enadoline has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnell, AJ; Field, MJ; Gonzalez, MI; Hughes, J; McCleary, S; Oles, RJ; Singh, L; Smith, R | 1 |
| Brotchie, JM; Hill, MP | 1 |
| Kusumoto, K; Mackay, KB; McCulloch, J | 1 |
3 other study(ies) available for enadoline and Disease Models, Animal
| Article | Year |
|---|---|
Enadoline, a selective kappa-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain.
Topics: Anesthesia Recovery Period; Animals; Benzofurans; Blood Gas Analysis; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Morphine; Pain, Postoperative; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Respiratory Mechanics; Skin; Touch | 1999 |
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzofurans; Biogenic Monoamines; Clonidine; Disease Models, Animal; Drug Combinations; Drug Synergism; Locomotion; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Prazosin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Yohimbine | 1999 |
The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia.
Topics: Animals; Benzofurans; Brain Edema; Cerebral Infarction; Disease Models, Animal; Ischemic Attack, Transient; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa | 1992 |